MD Archives - Page 9 of 12

Jehan Al Rayahi

Dr. Jehan Al Rayahi joined Sidra Medicine in 2018. She is the Division chief of neuro-imaging and an attending pediatric neuroradiologist. She is also the program director of both their pediatric radiology and Pediatric Neuroradiology fellowship programs.

Dr. Jehan is a Weill Cornell Medicine graduate from the inaugural class of 2008. She completed her residency at Hamad Hospital in Qatar. She then completed two fellowships in pediatric radiology and pediatric neuroradiology at the Hospital of Sick Children in Toronto, Canada. Her main interests and research are in the genomics of pediatric neuroradiology.

Dr. Jehan is also interested in pediatric epilepsy research and is the lead neuroradiologist in Sidra’s Epilepsy Surgical Program.

9 July, 2024

Sidra Medicine Signs MoU with Children’s National

Partnership to enable Nursing Best Practices and Excellence Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with Children’s National Hospital from Washington D.C., to establish a

1 July, 2024

Sidra Medicine Becomes First Hospital in Qatar to Administer Revolutionary Gene Therapy Medication

Life-saving drug from Roche Pharmaceuticals now available in Qatar for children with Duchenne Muscular Dystrophy Chris El Kik becomes first patient to receive treatment for DMD Doha, Qatar, 1 July

30 June, 2024

Accurate and Timely Diagnoses Now a Reality with Whole Genome Sequencing at Sidra Medicine

Hope for Patients with Complex Medical Conditions and Rare Diseases 30 June 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is pleased to announce that it has successfully implemented

9 June, 2024

Sidra Medicine Celebrates Second Medical Education Day

Sidra Medicine, a member of Qatar Foundation, celebrated its second Medical Education Day on 8 June 2024 at The Ritz Carlton Hotel to honor its batch of 2023-2024 graduate residents, fellows, and medical students.

15 May, 2024

Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders

15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th and 10th of

14 May, 2024

Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program

14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hematopoietic stem cell transplant (HSCT) program in Qatar, in partnership with one of the world’s leading pediatric hospitals, Children’s Hospital of Philadelphia (CHOP).

22 April, 2024

Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East

A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the prestigious Genome Medicine journal1.

1 April, 2024

First Arab Middle Eastern Genetics Research in Autism Going Global

On World Autism Awareness Day, Sidra Medicine, a member of Qatar Foundation, celebrates the profound impact of its long-standing initiative, the BARAKA-Qatar study1 (Building a Resource for the Advancement of Knowledge of Autism in Qatar).

12 March, 2024

Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer

12 March 2024, Doha, Qatar – Sidra Medicine has appointed Mr. Wouter Van den Brande as its new Chief Operating Officer (COO). As COO of Sidra Medicine, Wouter's responsibilities will include overseeing and expanding the